scholarly journals Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures

2016 ◽  
Vol 141 (1) ◽  
pp. 95-100 ◽  
Author(s):  
Boris Winterhoff ◽  
Habib Hamidi ◽  
Chen Wang ◽  
Kimberly R. Kalli ◽  
Brooke L. Fridley ◽  
...  
Keyword(s):  
Gene Expression ◽  
Ovarian Cancer ◽  
Clear Cell ◽  
Molecular Classification ◽  
High Grade ◽  
Gene Expression Signatures

Abstract 5597: Molecular classification of glioblastoma multiforme using isoform-level gene expression signatures.

2013 ◽  
Author(s):  
Sharmistha Pal ◽  
Yingtao Bi ◽  
Lukasz Macyszyn ◽  
Louise C. Showe ◽  
Donald M. O'Rourke ◽  
...  
Keyword(s):  
Gene Expression ◽  
Glioblastoma Multiforme ◽  
Molecular Classification ◽  
Gene Expression Signatures

scholarly journals Prognostic gene expression signature for high-grade serous ovarian cancer

2020 ◽  
Vol 31 (9) ◽  
pp. 1240-1250 ◽  
Author(s):  
J. Millstein ◽  
T. Budden ◽  
E.L. Goode ◽  
M.S. Anglesio ◽  
A. Talhouk ◽  
...  
Keyword(s):  
Gene Expression ◽  
Ovarian Cancer ◽  
Gene Expression Signature ◽  
High Grade ◽  
Serous Ovarian Cancer ◽  
Expression Signature ◽  
Prognostic Gene

Molecular Classification of Light Chain (Al) Amyloidosis by Gene Expression Profiling

2004 ◽  
pp. 58-60
Author(s):  
R Abraham ◽  
R Fonseca ◽  
M Manske ◽  
T Price-Troska ◽  
M Gertz ◽  
...  
Keyword(s):  
Gene Expression ◽  
Gene Expression Profiling ◽  
Light Chain ◽  
Expression Profiling ◽  
Molecular Classification ◽  
Al Amyloidosis

scholarly journals The forkhead box L2 transcription factor (FOXL2) is differentially expressed in high-grade serous ovarian cancers.

2020 ◽  
Author(s):  
Shahan Mamoor
Keyword(s):  
Gene Expression ◽  
Ovarian Cancer ◽  
Expression Profiles ◽  
Gynecologic Cancer ◽  
Ovarian Tumors ◽  
High Grade ◽  
Normal Ovary ◽  
Primary Tumors ◽  
Forkhead Box ◽  
Ovarian Cancers

Ovarian cancer is the most lethal gynecologic cancer (1). We sought to identify genes associated with high-grade serous ovarian cancer (HGSC) by comparing global gene expression profiles of normal ovary with that of primary tumors from women diagnosed with HGSC using published microarray data (2, 3). We identified the forkhead box L2, (FOXL2) (4) as among the genes whose expression was most different in HGSC ovarian tumors. FOXL2 expression was significantly lower in ovarian tumors relative to normal ovary. FOXL2 has established roles in ovarian development (4, 5), and the FOXL2 gene is mutated in granulosa-cell tumors of the ovary (6). These data indicate FOXL2 might also be perturbed, at the level of gene expression, in high-grade serous ovarian cancers.

P173 Plasma and tumour tissue TP53-gene expression in patients with high grade serous advanced ovarian cancer

2019 ◽  
Author(s):  
J Martinez-Garcia ◽  
P Sanchez Henarejos ◽  
MD Jimenez Lucas ◽  
A Puertes Boix ◽  
A Anton Garcia ◽  
...  
Keyword(s):  
Gene Expression ◽  
Ovarian Cancer ◽  
Advanced Ovarian Cancer ◽  
Tp53 Gene ◽  
Tumour Tissue ◽  
High Grade

scholarly journals Molecular Classification of Parathyroid Neoplasia by Gene Expression Profiling

2004 ◽  
Vol 165 (2) ◽  
pp. 565-576 ◽  
Author(s):  
Carl Morrison ◽  
William Farrar ◽  
Jeff Kneile ◽  
Nita Williams ◽  
Yiwen Liu-Stratton ◽  
...  
Keyword(s):  
Gene Expression ◽  
Gene Expression Profiling ◽  
Expression Profiling ◽  
Molecular Classification ◽  
Parathyroid Neoplasia
Sign in / Sign up

Export Citation Format

Share Document